Published in Semin Dial on January 13, 2004
Acetate-free blood purification can impact improved nutritional status in hemodialysis patients. J Artif Organs (2011) 0.83
Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules. Am J Kidney Dis (2008) 0.81
A Better Diet Quality is Attributable to Adequate Energy Intake in Hemodialysis Patients. Clin Nutr Res (2015) 0.75
Family history of chronic renal failure is associated with malnutrition in Korean hemodialysis patients. Nutr Res Pract (2009) 0.75
Kidney-brain crosstalk in the acute and chronic setting. Nat Rev Nephrol (2015) 0.75
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med (2003) 5.01
The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol (2003) 3.15
Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med (2003) 2.22
Tenofovir nephrotoxicity: 2011 update. AIDS Res Treat (2011) 1.94
Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol (2007) 1.94
Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Nephrol Dial Transplant (2010) 1.64
Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61
Risk factors for abdominal wall complications in peritoneal dialysis patients. Perit Dial Int (2003) 1.60
The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet (2009) 1.57
Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin Endocrinol (Oxf) (2013) 1.54
Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab (2004) 1.48
The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. J Am Soc Nephrol (2011) 1.45
Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope. J Hepatol (2008) 1.45
Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis (2005) 1.42
[Assessment and management of kidney disease in the HIV-1-infected patient. A practical review]. Enferm Infecc Microbiol Clin (2010) 1.39
Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol (2011) 1.33
European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. Nephrol Dial Transplant (2005) 1.28
TNF superfamily: a growing saga of kidney injury modulators. Mediators Inflamm (2010) 1.20
Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) (2003) 1.19
The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant (2004) 1.18
Analysis of patient flow into dialysis: role of education in choice of dialysis modality. Perit Dial Int (2005) 1.16
Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) (2005) 1.16
Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function. Perit Dial Int (2005) 1.15
BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrol Dial Transplant (2010) 1.15
Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. Nephrol Dial Transplant (2011) 1.14
Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival. PLoS One (2012) 1.13
Pharmacological therapy of Cushing's syndrome: drugs and indications. Mini Rev Med Chem (2007) 1.09
Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. Eur J Endocrinol (2012) 1.09
Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function. Clin Endocrinol (Oxf) (2002) 1.08
TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21. PLoS One (2010) 1.07
Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch (2004) 1.06
Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int (2006) 1.06
Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane. J Am Soc Nephrol (2009) 1.06
Outcome and prognostic factors in HIV-1-infected patients on dialysis in the cART era: a GESIDA/SEN cohort study. J Acquir Immune Defic Syndr (2011) 1.03
Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial (2003) 1.02
CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J Am Soc Nephrol (2009) 1.01
Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharm Res (2008) 1.01
Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. J Biol Chem (2006) 1.01
Birth weight impacts on wave reflections in children and adolescents. Hypertension (2002) 1.01
Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Investig Drugs (2005) 1.00
Chronic exposure of mouse peritoneum to peritoneal dialysis fluid: structural and functional alterations of the peritoneal membrane. Perit Dial Int (2009) 0.99
A multicentric survey of the practice of hand hygiene in haemodialysis units: factors affecting compliance. Nephrol Dial Transplant (2005) 0.99
Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study. Crit Care (2013) 0.98
Thrombotic microangiopathy associated with use of interferon-beta. Int J Nephrol Renovasc Dis (2012) 0.98
Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (2005) 0.98
Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy. Nephrol Dial Transplant (2009) 0.98
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab Invest (2010) 0.96
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis. Nephrol Dial Transplant (2008) 0.96
Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex. Nephrol Dial Transplant (2010) 0.96
Long-term virological follow up of patients with occult hepatitis C virus infection. Liver Int (2011) 0.95
Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance. Nephrol Dial Transplant (2006) 0.95
Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril (2012) 0.94
Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit Dial Int (2011) 0.94
Appetite disorders in uremia. J Ren Nutr (2008) 0.94
Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): a possible new marker of systemic endothelial dysfunction? Nephrol Dial Transplant (2008) 0.93
Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes. Clin Chem Lab Med (2011) 0.93
Selenium and kidney disease. J Nephrol (2012) 0.92
Prognostic value of cell-free plasma DNA in patients with cardiac arrest outside the hospital: an observational cohort study. Crit Care (2010) 0.92
European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. Nephrol Dial Transplant (2005) 0.90
Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate. Adv Perit Dial (2004) 0.90
[GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)]. Enferm Infecc Microbiol Clin (2005) 0.90
In situ kidney insonation with microbubble contrast agents does not cause renal tissue damage in a porcine model. J Ultrasound Med (2008) 0.90
Diagnosis of occult hepatitis C without the need for a liver biopsy. J Med Virol (2010) 0.89
Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. PLoS One (2013) 0.89
A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury. PLoS One (2009) 0.89
Inflammation and malnutrition as predictors of mortality in patients on hemodialysis. J Nephrol (2002) 0.88
Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis. Clin J Am Soc Nephrol (2010) 0.88
Ultrasonography in kidney transplantation: values and new developments. Transplant Rev (Orlando) (2009) 0.88
Fn14 in podocytes and proteinuric kidney disease. Biochim Biophys Acta (2013) 0.87
High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients. Am J Nephrol (2009) 0.87
Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor. Nephrol Dial Transplant (2005) 0.86
Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease. J Ren Nutr (2012) 0.86
Octreotide reduces hepatic, renal and breast cystic volume in autosomal-dominant polycystic kidney disease. Int Urol Nephrol (2010) 0.86
Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial (2002) 0.86
Influence of bicarbonate/low-GDP peritoneal dialysis fluid (BicaVera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells. Perit Dial Int (2012) 0.85
KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients. Clin Transplant (2011) 0.85
European best practice guidelines for peritoneal dialysis. 6 Automated peritoneal dialysis. Nephrol Dial Transplant (2005) 0.85
TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease. Front Immunol (2013) 0.85
Association of cell-free plasma DNA with perioperative mortality in patients with suspected acute mesenteric ischemia. Clin Chim Acta (2010) 0.85
Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis. Adv Perit Dial (2007) 0.84
Effect of different dialysis modalities on microinflammatory status and endothelial damage. Clin J Am Soc Nephrol (2010) 0.84
The role of depression, anxiety, stress and adherence to treatment in dialysis patients health-related quality of life: a systematic review of the literature. Nefrologia (2014) 0.83
Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study. Nefrologia (2013) 0.83
Nephrotic syndrome and idiopathic membranous nephropathy associated with autosomal-dominant polycystic kidney disease. ScientificWorldJournal (2011) 0.83
Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells. PLoS One (2012) 0.83
Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis. Psicothema (2013) 0.83
Lipoatrophic diabetes in an elderly woman: clinical course and serum adipocytokine concentrations. Endocr J (2004) 0.83
Hepatitis C virus infection in the family setting of patients with occult hepatitis C. J Med Virol (2009) 0.83
European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. Nephrol Dial Transplant (2005) 0.83
Regulation of apoptosis by lethal cytokines in human mesothelial cells. Kidney Int (2003) 0.83
Phase I and phase IB clinical trials for the noninvasive evaluation of intestinal lactase with 4-galactosylxylose (gaxilose). J Clin Gastroenterol (2013) 0.83
Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study. Nephrol Dial Transplant (2004) 0.82